Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Chemokine CCR4 receptor modulators designed by Tularik researchers

Feb. 26, 2003

Kowa claims four series of cell adhesion inhibitors for allergy, asthma, etc.

Feb. 26, 2003

Results from phase III Surfaxin trial will be delayed several months

Feb. 25, 2003

Novel chemokine CCR3 modulators and their use in asthma and rhinitis

Feb. 25, 2003

Adenylate cyclase activators discovered at Nippon Kayaku

Feb. 20, 2003

CV Therapeutics claims adenosine A2B antagonists for asthma and other uses

Feb. 19, 2003

New chemokine receptor modulators in early development at Ono

Feb. 18, 2003

Antiallergic benzopyrans in early development at Japanese lab

Feb. 17, 2003

New IL-4 production inhibitors identified by Mitsubishi Pharma researchers

Feb. 17, 2003

BCY LifeSciences updates status of phase II DCF-987 trial in cystic fibrosis

Feb. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...